Home LiteratureArticle Details
PMID: 20534450 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity.

Cella M, Otero K, Colonna M

Abstract

Natural killer-22 (NK-22) cells are a human NK cell subset situated in mucosal-associated lymphoid tissues that specialize in IL-22 secretion in response to IL-23. Here we investigated the cytokine requirements for NK-22 cell expansion. IL-7 maintained the survival of NK-22 cells and IL-22 production in response to IL-23 but was insufficient to induce robust expansion. Proliferation of NK-22 cells was increased markedly by adding either IL-1beta or IL-2 to IL-7 and was even stronger in the presence of IL-1beta plus IL-2. In contrast to IL-7, continuous culture in IL-1beta and IL-2 modified NK-22 cytokine profiles. IL-1beta promoted constitutive IL-22 secretion rather than acute IL-22 production in response to IL-23 and induced IL-17 in some cells. IL-2 reduced secretion of IL-22 and IL-17, increasing production of IFN-gamma and leukemia inhibitory factor. Functional deviation toward IFN-gamma production also was induced by continuous culture in IL-23. These results demonstrate the functional plasticity of NK-22 cells, which may allow flexible responses to different pathogens. Finally, we found that NK-22 cells released the B-cell survival factor, B-cell activating factor belonging to the TNF family (BAFF), suggesting a potential role of NK-22 cells in promoting B-cell-mediated mucosal immunity.

MeSH Terms
B-Cell Activating Factor/biosynthesis Base Sequence Cell Proliferation/drug effects Cytokines/biosynthesis,genetics DNA Primers/genetics Humans In Vitro Techniques Interferon-gamma/biosynthesis Interleukin-1beta/pharmacology Interleukin-2/pharmacology Interleukin-23 Subunit p19/pharmacology Interleukin-7/pharmacology Interleukins/biosynthesis Killer Cells, Natural/classification,cytology,drug effects,immunology Leukemia Inhibitory Factor/biosynthesis Lymphocyte Subsets/classification,cytology,drug effects,immunology Palatine Tonsil/cytology,immunology RNA, Messenger/genetics,metabolism Recombinant Proteins/pharmacology
Chemicals
B-Cell Activating Factor Cytokines DNA Primers IL2 protein, human IL23A protein, human IL7 protein, human Interleukin-1beta Interleukin-2 Interleukin-23 Subunit p19 Interleukin-7 Interleukins LIF protein, human Leukemia Inhibitory Factor RNA, Messenger Recombinant Proteins TNFSF13B protein, human Interferon-gamma interleukin-22
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Cella Marina
Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110, USA.
Otero Karel
Colonna Marco
References (27)
27 references, click to expand
  1. Dual role of melanoma cell adhesion molecule (MCAM)/CD146 in lymphocyte endothelium interaction: MCAM/CD146 promotes rolling via microvilli induction in lymphocyte and is an endothelial adhesion receptor.
    J Immunol. 2007 Nov 15;179(10):6673-85 PMID: 17982057
  2. The functional plasticity of T cell subsets.
    Nat Rev Immunol. 2009 Nov;9(11):811-6 PMID: 19809471
  3. Human natural killer cell development.
    Immunol Rev. 2006 Dec;214:56-72 PMID: 17100876
  4. Alveolar epithelial STAT3, IL-6 family cytokines, and host defense during Escherichia coli pneumonia.
    Am J Respir Cell Mol Biol. 2008 Jun;38(6):699-706 PMID: 18192501
  5. Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells.
    J Exp Med. 2010 Feb 15;207(2):281-90 PMID: 20142432
  6. Crystal structure of HAb18G/CD147: implications for immunoglobulin superfamily homophilic adhesion.
    J Biol Chem. 2008 Jun 27;283(26):18056-65 PMID: 18430721
  7. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity.
    Nature. 2009 Feb 5;457(7230):722-5 PMID: 18978771
  8. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins.
    Nature. 2008 May 1;453(7191):106-9 PMID: 18362914
  9. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice.
    J Clin Invest. 2009 Mar;119(3):565-72 PMID: 19188681
  10. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense.
    Immunity. 2008 Dec 19;29(6):958-70 PMID: 19084435
  11. Cracking the BAFF code.
    Nat Rev Immunol. 2009 Jul;9(7):491-502 PMID: 19521398
  12. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells.
    Nat Immunol. 2009 Jan;10(1):66-74 PMID: 19029905
  13. Late developmental plasticity in the T helper 17 lineage.
    Immunity. 2009 Jan 16;30(1):92-107 PMID: 19119024
  14. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells.
    Eur J Immunol. 2009 Jan;39(1):216-24 PMID: 19130584
  15. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin.
    Nat Immunol. 2009 Jan;10(1):75-82 PMID: 19029904
  16. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity.
    Immunity. 2009 Jul 17;31(1):15-23 PMID: 19604490
  17. Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22.
    Blood. 2009 Apr 23;113(17):4008-10 PMID: 19244159
  18. Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair?
    Nat Rev Immunol. 2009 Apr;9(4):229-34 PMID: 19319141
  19. IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors.
    J Exp Med. 2010 Feb 15;207(2):273-80 PMID: 20142427
  20. RANKL is necessary and sufficient to initiate development of antigen-sampling M cells in the intestinal epithelium.
    J Immunol. 2009 Nov 1;183(9):5738-47 PMID: 19828638
  21. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity.
    Immunol Rev. 2003 Oct;195:117-35 PMID: 12969315
  22. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling.
    Immunity. 2009 Apr 17;30(4):576-87 PMID: 19362022
  23. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation.
    Immunity. 2007 Mar;26(3):371-81 PMID: 17363300
  24. IL-22: a critical mediator in mucosal host defense.
    J Mol Med (Berl). 2009 May;87(5):451-4 PMID: 19219418
  25. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo.
    Nat Immunol. 2009 Mar;10(3):314-24 PMID: 19182808
  26. IL-22 and inflammation: leukin' through a glass onion.
    Eur J Immunol. 2008 Dec;38(12):3265-8 PMID: 19016525
  27. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells.
    Nat Immunol. 2009 Jan;10(1):83-91 PMID: 19029903
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
1091-6490
Published
2010-06-15
Epub
2010-00-01
Pages
10961-6
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC2890739
Subset
IM
Grants
NIDDK NIH HHS · P30 DK056341 · United States
NIDDK NIH HHS · P30 DK056341-10 · United States
PHS HHS · A1067854 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com